Blockchain Registration Transaction Record

Cingulate's CTx-1301: A Game-Changer in ADHD Treatment

Cingulate Inc.'s CTx-1301 could transform ADHD treatment with its innovative once-daily formula, addressing key market needs. Learn more about this breakthrough.

Cingulate's CTx-1301: A Game-Changer in ADHD Treatment

This news is pivotal for millions affected by ADHD, offering hope for a more effective and convenient treatment option. The success of CTx-1301 could significantly improve daily life for patients and families, reducing the burden of current treatment limitations.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x193b258a7fbe36b045b93a1eea031329693e338acb28fa934a9090f584b7d327
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintninat9iq-eecb2f04782320c82579490f89a4833e